RF&L Wealth Management’s Eli Lilly LLY Stock Holding History

RF&L Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.1M	Sell	3,369 -161	-5%	-$163K	2.32%	14
2025 Q4	$3.79M	Sell	3,530 -149	-4%	-$142K	2.13%	19
2025 Q3	$2.81M	Sell	3,679 -25	-0.7%	-$18.6K	1.65%	22
2025 Q2	$2.89M	Hold	3,704	–	–	1.86%	20
2025 Q1	$3.06M	Hold	3,704	–	–	2.19%	17
2024 Q4	$2.86M	Hold	3,704	–	–	2.02%	17
2024 Q3	$3.28M	Sell	3,704 -30	-0.8%	-$27K	2.32%	17
2024 Q2	$3.38M	Sell	3,734 -150	-4%	-$120K	2.57%	15
2024 Q1	$3.02M	Sell	3,884 -330	-8%	-$235K	2.33%	17
2023 Q4	$2.46M	Sell	4,214 -100	-2%	-$58.4K	2.04%	16
2023 Q3	$2.32M	Sell	4,314 -360	-8%	-$186K	2.15%	15
2023 Q2	$2.19M	Sell	4,674 -370	-7%	-$155K	2%	16
2023 Q1	$1.73M	Sell	5,044 -150	-3%	-$50.6K	1.68%	16
2022 Q4	$1.9M	Buy	+5,194	New	+$1.84M	1.96%	15

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

RF&L Wealth Management's LLY Position: Q1 2026 in Review

RF&L Wealth Management reduced its Eli Lilly (LLY) stake by 4.6% in Q1 2026, selling an estimated $163K and leaving 3,369 shares worth $3.1M. The position accounts for 2.32% of the portfolio, ranked #14.

RF&L Wealth Management first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.79M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

RF&L Wealth Management held 3,369 shares of Eli Lilly worth $3.1M as of Q1 2026.
RF&L Wealth Management sold 161 Eli Lilly shares in Q1 2026, an estimated $163K.
Eli Lilly made up 2.32% of RF&L Wealth Management's portfolio in Q1 2026, its #14 holding.
RF&L Wealth Management first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
RF&L Wealth Management's Eli Lilly position peaked at $3.79M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on RF&L Wealth Management's 13F filing for Q1 2026, filed 14 Apr 2026.